Towards Healthcare
Third-Party Medical Institutions Market
Updated Date: 16 January 2026   |   Report Code: 5250

Third-Party Medical Institutions Market Plays a Key Role in Modern Healthcare Systems

Market insights predict the global third-party medical institutions industry will increase from USD 254.88 billion in 2025 to USD 528.27 billion by 2035, achieving a CAGR of 7.56%. The global third-party medical institutions market is expanding as healthcare demand rises, especially with North America leading in 2023. These institutions provide essential services like diagnostics and rehabilitation, helping hospitals manage patient care. Asia Pacific is set to grow the fastest by 2034.

Last Updated : 16 January 2026 Category: Healthcare Services Insight Code: 5250 Format: PDF / PPT / Excel
Revenue, 2025
USD 254.88 Billion
Forecast, 2035
USD 528.27 Billion
CAGR, 2026-2035
7.56%
Report Coverage
Global

The third-party medical institutions market size was valued at US$ 254.88 billion in 2025 and is projected to grow to 274.15 billion in 2026. Forecasts suggest it will reach approximately US$ 528.27 billion by 2035, registering a CAGR of 7.56% during the period.

Third-Party Medical Institutions Market Trends and Growth (2026)

The global third-party medical institutions market size is on an upward trajectory, poised to generate substantial revenue growth, potentially climbing into the hundreds of millions over the forecast years from 2024 to 2034. This surge is attributed to evolving consumer preferences and technological advancements reshaping the industry. The demand for third-party institutions is increasing due to the growing senior population. This population constantly needs medical support. However, hospitals are fully occupied most of the time, and hence, not everyone can visit the hospital for healthcare purposes and seek medical attention from third-party institutions.

Key Takeaways

  • Third-party medical institutions industry poised to reach USD 274.15 billion by 2026.
  • Forecasted to grow to USD 528.27 billion by 2035.
  • Expected to maintain a CAGR of 7.56% from 2026 to 2035.
  • North America dominated the global third-party medical institutions market in 2024.
  • Asia Pacific is expected to be the fastest-growing during the forecast period.
  • By type, the technical medical third-party institutions segment dominated the market in 2024.
  • By type, the clinical medical third-party institutions segment is estimated to grow significantly at a notable CAGR during the forecast period.
  • By application type, the hospital segment dominated the global third-party medical institutions market in 2024.

Key Indicators and Highlights

Key Elements Scope
Market Size in 2026 USD 274.15 Billion
Projected Market Size in 2035 USD 528.27 Billion
CAGR (2026 - 2035) 7.56%
Leading Region North America
Market Segmentation By Type, By Application, By Region
Top Key Players Steriguard Medical, Julikang, Aecssd Medical, Laoken Medical, LabCorp, Sonic Healthcare, Quest Diagnostics, Unilabs, Sterigenics, STERIS, DaVita, Baxter, Fresenius

Market Overview

The third-party medical institutions market comprises healthcare providers that operate independently outside the significant medical systems and hospitals. Third-party service providers include laboratories, clinics, rehabilitation centers, and imaging centers. These institutions provide various healthcare services in specialized areas or multiple areas of healthcare. The institutions also collaborate with major healthcare systems to mitigate the gaps in medical services and provide support in various areas such as care options, diagnostics, and treatment. The market is growing significantly due to the growing number of patients. It becomes hectic and complicated for hospitals to handle all the services associated with patient care; hence, third-party medical institutions support hospitals to provide quality care.

  • In August 2024, in an attempt to strengthen its position in the market, the biggest third-party administrator (TPA), Medi Assist Insurance, finally agreed to pay Rs 311.18 crore to buy Paramount Health Services & Insurance TPA.
  • In June 2024, the Union Ministers of State Health and Family Welfare launched 3 initiatives, one of which was the “National Quality Assurance Standards for Integrated Public Health Laboratories.”

Market Dynamics

Growth Factors

  • Increasing occurrences of chronic diseases: The rising incidence of chronic diseases is increasing the demand for the use of various diagnostic as well as effective treatment options, which are provided by third-party medical institutions.
  • Convenient testing services: The third-party medical institutions provide affordable, as well as point-of-care testing and monitoring services to the patients. This improves patient outcomes.
  • Telemedicine: They offer the services of telemedicine to the patients, which enhances the patient outcomes in rural areas or in areas with limited hospital facilities.

Chronic Conditions Need Third-Party Medical Services

Prevalance of Chonic Conditions by 2040

Chronic conditions pose a huge burden on healthcare resources and hospitals. Chronic conditions require continuous monitoring and treatment to avoid emergency situations. The growing elderly population and unhealthy lifestyles are the major causes of the growing number of patients with chronic conditions. Third-party medical institutions play a significant role in supporting major medical systems by providing test results, data analysis, and treatment options. Many third-party institutions specialize in one area and are capable of providing better services to highly skilled professionals.

Challenge: Varying Healthcare Policies

The third-party medical institutions market faces challenges because of the continuous changes in healthcare policies. The institutions need to strictly stick to the rules and guidelines provided in the new policies to avoid any legal issues, which becomes a challenge in the long run.

Segment Insights

By Type Insights

Why Did the Technical Medical Third-Party Institutions Segment Dominate in the Third-Party Medical Institutions Market?

By type, the technical medical third-party institutions segment dominated the third-party medical institutions market. These institutions provide various services in the medical industry but services are not directly related to healthcare. The services include maintenance & calibration of medical equipment, technical support, and data analysis. Such institutions are in high demand because they reduce healthcare costs by maintaining equipment and other functions.

Clinical Medical Third-Party Institutions

By type, the clinical medical third-party institutions segment is expected to grow at the fastest rate during the forecast period. These institutions are becoming popular as they provide specialized clinical services. Services provided by these institutions include medical testing, clinical trials, data analysis, and specialized medical procedures. They play a crucial role in providing support to hospitals to improve the quality of care.

By Application Insights

How Hospital Segment Dominated the Third-Party Medical Institutions Market?

By application, the hospital segment held the largest share of the market in 2023. Many patients visit hospitals daily, and many tests are conducted daily to diagnose diseases and develop proper treatment options. It becomes hectic for hospital staff to handle everything on their own, and hospitals collaborate with third-party institutions to run tests, analyze data, and provide treatments.

Regional Insights

Advanced Healthcare Drives North America

North America Dominated the third-party medical institutions market. North America is home to advanced healthcare infrastructure, technological advancements, and highly skilled healthcare professionals, all of which contribute to the market’s growth. There are several other factors that add up to the growth, including government initiatives, collaboration among key players, investments by government & organizations, and growing awareness among people. The U.S. and Canada have contributed significantly to the growth.

U.S. Third-Party Medical Institutions Market Trends

The U.S. is the major shareholder in the third-party medical institutions market due to the presence of a highly advanced medical system, health insurance companies, and partnerships between different organizations. Another major factors that contribute to the market’s growth is the growing prevalence of diseases like obesity, cancer, diabetes, COPD, cardiovascular diseases, etc. Also, there is a strong presence of healthcare laboratories in the U.S. that are responsible for providing top-quality care.  According to the Centers for Disease Control and Prevention, there are more than 330,000 CLIA-certified laboratories in the U.S. responsible for conducting 14 billion tests annually. Around 70% of medical decisions depend on these laboratory tests.

Canada Third-Party Medical Institutions Market Trends

Canada held the second-largest share of the third-party medical institutions market in 2023. Canada has a strong presence of third-party institutions such as physicians' offices and diagnostic laboratories. According to the Government of Canada, there were 99,142 physicians' offices and 4,215 medical & diagnostics laboratories in Canada. The government is also investing significantly in the life science sector to improve healthcare services.

For instance,

  • In May 2024, In order to assist the creation of a new 20,000-square-foot wet lab facility in Mississauga specifically for forward-thinking life science enterprises, FedDev Ontario invested $5 million in the SPEC Labs Centre for Advancement in Biomedical Innovation.

Asia Pacific Emerges as a Key Growth Engine for Third-Party Medical Institutions

Asia Pacific is expected to grow at the fastest rate during the forecast period. Asia Pacific is advancing in healthcare systems and technology. Governments and various organizations are taking necessary steps to promote the growth of the third-party medical institutions market in Asia Pacific. The region consists of the largest population, which puts the burden on the healthcare sector. Therefore, third-party institutions are important for addressing healthcare needs. The region also has a growing number of various diseases, including diabetes, cancer, COPD, and infectious diseases.

India Third-Party Medical Institutions Market Trends

India is a significant contributor to the market’s growth because there has been a growing number of policies and investments by the government and organizations to improve the country's healthcare system. For instance, the number of DMCs has increased by 80% from 2014 (13583) to 2023 (24449). In the last decade, there have been 6196 new molecular diagnostic laboratories, and TB treatment centers’ numbers increased from 127 in 2014 to 792 in 2022. Apart from this, the ABPM-JAY scheme launched by the India Government is also promoting people's use of healthcare services. For instance, under this program, there has been a total of 6.11 crore hospital admissions accounting for Rs. 78,188 crores, out of which 1.7 crore admissions occurred in 2023, which accounted for Rs. 25,000 crores.

For instance,

  • In August 2024, according to people with knowledge of the situation who spoke with CNBC-TV18, Bessemer India signed a block agreement of ₹540.94 crore to acquire Medi Assist Healthcare Services, which provides insurance companies with third-party administration services.

Europe Embraces Innovation as a Key Growth Driver for Third-Party Medical Institutions

Europe is expected to grow significantly in the third-party medical institutions market during the forecast period. The third-party medical institutions in Europe are adopting various technological advancements that improve the services they provide to patients. This helps in the development of new diagnostic and treatment options at affordable prices. Thus, this promotes the market growth.

UK Third-Party Medical Institutions Market Trends

The influence of third-party medical institutions in the UK is increasing due to the convenient services they provide to the population. Furthermore, this attracts the aging population, which in turn, enhances the patient outcomes. Due to the advanced services offered by the third-party medical institutions in Germany, patients are preferring them. Moreover, the services are cost-effective as well as can help in remote monitoring, which increases patient adherence and satisfaction.

Expanding Healthcare Propel South America

South America is expected to grow significantly in the third-party medical institutions market during the forecast period, due to growth in the healthcare sector. At the same time, the growing outsourcing trend is also increasing their collaborations, where the affordable services are promoting the market growth.

Brazil Third-Party Medical Institutions Market Trends

Due to expanding healthcare in Brazil, the demand for third-party medical institutions is increasing. The growing chronic diseases and outsourcing trends are also increasing their demand, where the growing innovations are also being supported by government investments.

Outsourcing Trends Stimulate MEA

MEA is expected to grow significantly in the third-party medical institutions market during the forecast period, due to increasing outsourcing trends. The growing healthcare infrastructure and chronic disease rates are increasing the demand for accurate diagnostic and effective treatment options, driving their collaboration, and enhancing the market growth.

Saudi Arabia Third-Party Medical Institutions Market Trends

Rising demand for specialized services in Saudi Arabia is increasing the demand for third-party medical institutions. At the same time, affordable outsourcing and growing healthcare investments are leading to their collaboration to accelerate R&D activities and expand the diagnostic networks.

SWOT Analysis in the Third-Party Medical Institutions Market

Strengths

  • The growing geriatric population and the increasing prevalence of chronic disorders promote the demand for third-party medical institutions.
  • The rising demand for personalized medicines and treatment also bolsters market growth.
  • The increasing collaboration among key players enhances treatment accessibility across a wider patient population.

Weaknesses

  • Lack of skilled healthcare professionals is a significant challenge for market growth, as there is an insufficient number of doctors to treat a large patient population.
  • Certain patients from underdeveloped and developing countries are unaware of third-party medical institutions and their benefits, restricting market growth.

Opportunities

  • Technological advancements, such as AI, ML, and data analytics, help reach patients and provide personalized treatment.
  • Government organizations launch initiatives to support third-party medical institutions and also provide funding.

Threats

  • Healthcare organizations face regulatory and compliance risks as third-party institutions need to comply with local or international laws.
  • Supply chain disruption of pharmaceuticals and medical devices is caused by infrastructure gaps and heavy reliance on imports.

Collaboration Landscape: Third-Party Medical Institutions Market

  • In January 2026, Max Healthcare collaborated with Google to enable patients to book appointments directly through Google Search and Google Maps to speed up access to healthcare services.
  • In July 2025, Frenova, a Fresenius Medical Care company, and GENEWIZ collaborated to advance genomic analysis for Frenova’s My Reason genomics research program and leverage cutting-edge technologies to better understand chronic diseases.
  • In July 2025, the IMAGINE Consortium facilitates cross-sector collaboration between academic institutions, hospitals, and industry leaders to accelerate the development of medical imaging and image-guided, minimally invasive treatments in cancer care.

Recent Developments

  • In May 2024, in order to test medical devices for efficacy, safety, and quality, the Central government has partnered with up to 50 commercial laboratories.
  • In April 2024, TVM Capital Healthcare announced an investment of US$ 17 million in Munich-based neurocare group AG (neurocare), which offers tools to enable physicians to give their patients the best care possible.
  • In January 2024, Bajaj Finserv, via its fully-owned division Vidal Healthcare Services, the proprietor of a third-party administrator company, was purchased by Bajaj Finserv for an enterprise value of Rs 325 crore through its wholly-owned subsidiary Bajaj Finserv Health.

Top Companies in the Third-Party Medical Institutions Market

  • Steriguard Medical
  • Julikang
  • Aecssd Medical
  • Laoken Medical
  • LabCorp
  • Sonic Healthcare
  • Quest Diagnostics
  • Unilabs
  • Sterigenics
  • STERIS
  • DaVita
  • Baxter
  • Fresenius

Segments Covered in the Report

By Type

  • Technical Medical Third-Party Institutions
  • Clinical Medical Third-Party Institutions

By Application

  • Hospital
  • Clinic
  • Other

By Region

  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait

FAQ's

Answer : The market was valued at USD 254.88 billion in 2025, is expected to reach USD 274.15 billion in 2026, and is projected to grow to USD 528.27 billion by 2035 at a CAGR of 7.56%.

Answer : North America leads the market due to advanced healthcare infrastructure, strong government support, technological innovation, and a high concentration of key industry players.

Answer : Major companies include LabCorp, Quest Diagnostics, Sonic Healthcare, Sterigenics, STERIS, DaVita, Baxter, Fresenius, and several leading regional players.

Tags

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar

Related Reports